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Introduction
Lest we forget, within every higher organism, there are literally
billions of cells with identical genetic information that serve as
constituents of the different tissues and organs. Given that
genetic information is the same in all cells, including the stem
cells, by definition, cells in higher organisms do not possess a
sense of place or purpose by themselves.Therefore, in order for
each organ to operate successfully within the context of the
organism, all cells must be integrated into an architectural and
signaling framework such that each cell knows exactly which
commands to execute at any given time. Success at this daunt-
ing task leads to homeostasis, while failure results in a spec-
trum of dysfunctions, including cancer. How do organisms
achieve this remarkable feat, and how does each cell in return
know what to do within the tissues?
The microenvironment exerts control over the genome in
both normal and malignant cells
If the genome of differentiated cells had complete autonomy,
there would be no tissue specificity, and isolated cells would
continue to function in cell culture as they would in the organ.
This clearly is not the case: isolated cells are known to lose
most functional differentiation when separated and placed in
traditional cell cultures (Bissell, 1981). However, the cellular
identity is not lost permanently, as we have learned that by con-
trolling the microenvironment of the cells in culture, we can
make them “remember” many of their original tissue specific
traits (for review, see Bissell et al., 2003).
It is also known that over the lifespan of an organism, indi-
vidual cells incur multiple harmful genetic lesions due to envi-
ronmental exposure and physiologically induced reactive
oxygen species. If cancer were exclusively due to genetic muta-
tions, then we should expect every organ to eventually become
cancerous. Moreover, heritable cancer syndromes almost
exclusively affect just a single tissue type, even though every
cell contains the mutation. Therefore, in addition to known
defense mechanisms such as DNA repair, factors from the tis-
sue microenvironment must play key roles in cellular decision-
making and maintenance of homeostasis.
Experiments performed in chimeric mice and in chickens
have provided evidence of the delicate equilibrium maintained
by the normal microenvironment in spite of cells that might oth-
erwise be predisposed to neoplasia. One of the most dramatic
examples is that of studies by Mintz and Illmensee in which
embryonal carcinoma cells injected subcutaneously in mice
formed teratocarcinomas, whereas the same cells injected into
a blastocyst gave rise to normal chimeric mice instead of
tumors (Mintz and Illmensee, 1975). This experiment posed a
conundrum: Can a tumor cell beget a normal offspring? If can-
cer is only a genetic disease, were there cancer-causing muta-
tions in the teratoma cells, and if so why were the mice pheno-
typically normal? If there were no mutations in the teratoma,
how did it make tumors in the first place when injected subcuta-
neously? These and a number of other perplexing questions
were left unanswered as the field entered the exciting era fol-
lowing the discovery of oncogenes, suppressor genes, and the
role of genetic mutations in cancers. Thirty years earlier, the
same fate had befallen a series of experiments performed by
Duran-Reynals and his colleagues using Rous sarcoma virus
(RSV). In Nobel Prize-winning work, Rous had shown that RSV,
which contains one of the most potent oncogenes, pp60src (for
review, see Martin, 2001, 2004. and references therein), can
cause aggressive tumors when injected in the wing of a chick-
en; in doing so, he proved Koch’s postulate for the first tumor-
causing virus (Rous, 1979). However, experiments by Milford
and Duran-Reynals showed that RSV injected in the chick
embryos did not form tumors (Milford and Duran-Reynals,
1943). Subsequent discoveries that RSV caused transformation
of chick embryo fibroblasts in culture (Martin, 2004) rendered
findings in the embryo suspect, as virologists believed at the
time that the findings could be explained by lack of virus integra-
tion and/or gene expression in the chick embryo, and conse-
quently, these data were ignored for decades.
Many years later, we performed experiments in virus-free
chicken embryos infected in ovo with tagged pp60src, and
showed that the virus was expressed in most organs of the
infected embryos, but was not tumorigenic (Stoker et al., 1990).
However, if the infected embryos were dissociated and placed
in culture, there was mass transformation within 24 hr (Dolberg
and Bissell, 1984). Interestingly, even the tumors that formed in
adult chickens were shown to be dependent on the puncture
wound at the injection site or at distally wounded sites (Dolberg
et al., 1985). In one of the first demonstrations of the contradic-
tory roles of TGFβ in regulation of normal and malignant cells,
the molecule responsible was shown to be the wound-induced
TGFβ (Sieweke et al., 1990).There are many more examples of
the importance of context and the microenvironment in attenua-
tion or induction of tumors (Kenny and Bissell, 2003), and it is
interesting to note that there are now more than 900 entries in a
Google search on the relation between wounding, inflamma-
tion, and oncogenes, confirming the connection observed by
physicians and researchers as early as the mid-19th century (for
review, see Sieweke and Bissell, 1994). Such observations sup-
port the concept of cancer as a disease that must simultane-
ously subvert the microenvironmental controls as well as the
genetic program.
The examples discussed above were published decades
ago, but it is encouraging that current technologies are making it
possible to reexamine these findings at the molecular level.That
a single oncogene is not sufficient to induce tumors was con-
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firmed definitively by the first engineered oncomouse: tumors
were formed only in occasional cells rather than in all cells, were
heterogeneous, and had the appropriate latency (Stewart et al.,
1984). There are now numerous examples of other engineered
mice with different oncogenes, both with and without condition-
al expression, that attest to the need for additional mutations in
the cancer cells and/or additional promotion from the microenvi-
ronment. In a striking example of this principle, inappropriate
expression of different metalloproteinases (MMPs) leads to loss
of integrity of tissue microenvironment and eventually tumors;
here, an extracellular signal was shown to effectively act as an
oncogene (Sternlicht et al., 1999; for revies, see Wiseman and
Werb, 2002). Most recently, in a compelling and elegant permu-
tation of the Mintz and Illmensee experiments, nuclei from
malignant cancer cells were introduced into enucleated
oocytes, which were then used to generate embryonic stem
cells that were subsequently used to make chimeric mice.
Although the chimeras had a predisposition for malignancy, the
vast majority of their tissues were normal, apparently because
the malignant phenotype was held in check by the normal
microenvironment (Hochedlinger et al., 2004).
That genetic manipulation of stromal cells can result in
tumor formation strongly suggests that in some cases, the
source of mutation, and thus the original cause of the tumor,
may be the neighboring cells. A recent example is the interac-
tion between fibroblasts and epithelial cells in intraepithelial
neoplasia in prostate and invasive squamous cell carcinoma of
the forestomach. Experiments demonstrated that making stro-
mal fibroblasts unresponsive to TGFβ leads to unrestrained
epithelial cell growth and invasion. In this case, it was proposed
that the mutated fibroblasts generated HGF and thus an abnor-
mal paracrine signaling leading to epithelial tumors (Bhowmick
et al., 2004a; Radisky and Bissell, 2004), and this may be a gen-
eral principle, as some tumors appear to influence the develop-
ment of their own supportive environments. Neurofibromatosis,
e.g., affects 1 in 4000 people who are born heterozygous for the
tumor suppressor, neurofibromin (NF1); loss of both alleles in
Schwann cells is required to form neurofibromas. In addition to
loss of heterozygosity (LOH) in Schwann cells, the other sur-
rounding cells of the tumor must also become NF1 heterozy-
gotes for tumors to form, because the mast cells and fibroblasts
then produce factors to support the NF1 null Schwann cells
(Zhu et al., 2002).
Stromal cells are responsible for producing both many of
the ECM-degrading enzymes and most of the connective tissue
ECM. In some mammary carcinomas, stromal cells were shown
to have acquired unique chromosomal rearrangements relative
to the tumorigenic epithelium (Moinfar et al., 2000), and some
heritable diseases that afflict carriers with higher incidence of
cancer have been shown to be due to stromal defects (Howe et
al., 1998; Jacoby et al., 1997). Taken together, these examples
provide evidence to support the notion that the microenviron-
ment can function both as a powerful tumor suppressor even in
the presence of strong oncogene expression, and as a tumor
promoter for precancerous, or even apparently normal, cells
(Sternlicht et al., 1999).
Do tumors originate from mutated stem cells?
A frequent observation by pathologists has been that while
some malignancies resemble the organ of origin morphological-
ly and biochemically, many appear less differentiated and even
embryonic, as is the case of Wilm’s tumors and neuroblastomas
(Sell, 2004). There are a number of conclusions that may be
derived from these observations: (1) if the somatic cells are
severely damaged, they may be able to “dedifferentiate” to a
progenitor-like state; (2) tumor cells may encounter the right
microenvironment with appropriate biochemical signals as they
migrate out of the original tissue that would allow them to redif-
ferentiate, analogous to the “tumor reversion” scenario
observed in 3D cultures of breast tumor cells (Weaver et al.,
1997, and discussion below); and (3) some tumors may origi-
nate from “cancer stem cells” which could get reactivated in
specific sites to recreate the original tissue phenotype. The lat-
ter possibility is supported by observation of a phenomenon
coined “maturation arrest” due to the fact that within a tumor
there are cells that appear to be tissue-specific stem cells
(TSSC), arrested at a progenitor stage of development (Cozzio
et al., 2003). Whether TSSCs represent the cellular origin of
cancer is a distinct area of discussion, but the experiments that
support the concept have demonstrated that maturation arrest
is possible, and it is clear that the source of the signals that
cause the arrest would have to be from the local microenviron-
ment. By combining observations made in the human popula-
tion with more recent experimental evidence, the cancer stem
cell hypothesis can be extended to include the microenviron-
ment as a key player in both keeping cancer in check and in
releasing anticancer restraints.
It has been hypothesized and tested (though not yet
proven) that mutated mammary stem cells are the origin of
breast cancer (Al-Hajj et al., 2003; Smith and Boulanger, 2002),
and in this case, the structure of the organ provides insight into
how this may occur.The mammary gland consists of a bilayered
epithelium (the inner luminal epithelium and the outer myoep-
ithelium) that is ramified into a tree-like structure, in which each
branch is capped by a terminal end bud in the developing gland,
becoming lobules in the mature gland. By examining separate
branching structures, Deng et al. found unique signatures of
genomic loss of heterozygosity (LOH) in individual branches
(Deng et al., 1996), suggesting that mutations in single stem
cells during gland development in puberty may initiate genomic
instability in progeny cells, and ultimately, breast cancer.
All else being equal, the TSSCs that are thought to medi-
ate repair, replenishment, and regeneration of their respective
tissues must be maintained in a quiescent state until they are
called upon to act on behalf of the tissue. Their normal behav-
ior is strictly governed by the stem cell microenvironment, or
niche, which is composed of other cells, ECM, and other
secreted factors (reviewed in Ohlstein et al., 2004). A well-
studied example of this phenomenon involves hematopoietic
stem cells, which are modulated by BMP-related signaling and
the Notch pathway due to their association with osteoblasts in
trabecular bone (Calvi et al., 2003; Zhang et al., 2003).
Similarly, self-renewal and differentiation of neural stem cells
is controlled by their association with endothelial cells that sig-
nal through the Notch pathway, among others (Shen et al.,
2004). Though the niche may act to maintain stem cell quies-
cence for decades, these cells are highly dynamic once acti-
vated: an embryo develops from a single cell in 9 months, the
intestine regenerates rapidly and constantly, the liver recre-
ates itself in a few days after partial hepatectomy, and the
mammary gland involutes completely after lactation but
regenerates only after a few weeks. In the same fashion, the
microenvironment of the niche apparently also controls dam-
aged stem cells that may act as cancer progenitors, since
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many tumors can lie dormant or develop slowly for decades
before manifesting as a clinical outcome.
That tumors take a long time to develop is illustrated clearly
by the following examples. A large number of female patients,
including girls at puberty, living in Massachusetts in the United
States circa 1920–1950, underwent screening for tuberculosis
by use of an X-ray fluoroscope. Repeated exposure to fluoro-
scopes, as was generally done at the time, generated toxic
doses of irradiation, and retrospective analysis revealed a sig-
nificantly higher incidence of breast cancer in women who were
young at the time of irradiation than would have been predicted
by the frequency of breast cancer in the population at large.The
cancer occurred 25–30 years later in their lives (Hrubec et al.,
1989). Similar patterns of breast cancer are reported for sur-
vivors of the atomic bombs that were used in Japan, and the
incidence again was skewed to younger women (Carmichael et
al., 2003). It is fascinating that the patients described in both
studies were young at the time and developed breast cancer
only many years after their initial exposure, especially since we
now know that the microenvironment of the irradiated tissue
also becomes abnormal, as discussed below. How could a
mammary stem cell that had incurred deleterious genetic
lesions have been held in check for so long? Whether the rea-
son is the ability of the niche to be repaired more quickly in
young girls, which could then hold the mutated stem cells dor-
mant, or whether the stem cells had to acquire additional muta-
tions over the years, is an important area of research that could
help and guide decisions on chemoprevention and therapy in
the future.
How microenvironmental signals override genetic
infidelity
Physical damage of DNA is a long-known consequence of
exposure to excessive ionizing radiation. Pertinent to the above
hypothesis are the questions of how many deleterious genetic
lesions a cell can incur before the microenvironment can no
longer control its growth, and which signaling pathways are like-
ly to be most important for maintaining microenvironmental con-
trol over a damaged cell. Based on recent experiments in
culture and in vivo, we can elaborate a set of rules that define
which microenvironmental constituents and which cellular sen-
sors appear to be required to restrain a TSSC predisposed to
cancer.
It appears that cells can incur a great deal of damage to
their genetic programming and still remain phenotypically dor-
mant (Chin et al., 2004). In fact, even after the cells become
tumorigenic, they still can retain the aberrant genome, but for all
practical purposes still revert to a normal phenotype if tissue
polarity is restored. The HMT-3522 luminal epithelial cell line
was isolated from a reduction mammoplasty (Briand et al.,
1987). These cells were used to derive S1 cells that have a
number of mutations, but when injected into NOD/SCID mice
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Figure 1. A normal microenvironment can preserve the tissue architecture even in the presence of predisposed cells, and an aberrant microenvironment
can promote the mutated cells to form tumors
Normal (blue) and genetically damaged (yellow) tissue-specific stem cells are shown in their niche surrounded by an instructive microenvironment that is
composed of cellular (stroma), structural (ECM molecules), and soluble components (growth factors, cytokines, proteases, and hormones, among others).
Normal and damaged TSSC can regenerate and replenish their respective tissues of origin in response to normal microenvironmental cues (blue solid and
yellow dashed arrows). However, when balanced control over the TSSCs is altered, they can also give rise to tumors (yellow solid arrows). Cells in the cap
region of the virgin rodent mammary gland, and those in upper basal region of the ducts and possibly acini, thought by some to be the physical location of
the mammary stem cells, can give rise to both luminal and myoepithelial cells during development and lactation (Williams and Daniel, 1983); others assert
that the TSSCs are located throughout the gland (Smith and Boulanger, 2002). The same signals that promote normal stem cell activity could push a predis-
posed stem cell to initiate carcinoma of the breast. The skeletal muscle stem cell is shown in its characteristic satellite cell position; however, reports have
also shown that they may reside in interstitial spaces. Normally, during times of muscle regeneration, they fuse with muscle fibers to provide new myonuclei,
but under rare circumstances, they are thought to give rise to rhabdomyosarcomas (Keller et al., 2004; Tiffin et al., 2003). Skin stem cells residing in the bulge
region give rise to the root sheathe during the hair cycle, but in some cases are thought to be the origin of basal cell carcinomas (Owens and Watt, 2003).
The ependymal cells of the subventricular zone (SVZ) in the CNS normally give rise to astrocytes, neurons, and oligodendrocytes. Under some conditions,
however, they are known as the cause of ependycytomas or astrocytomas (Maher et al., 2001).
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are nonmalignant; when cultured in 3D, laminin-rich basement
membrane gels that recapitulate the normal niche, they growth-
arrest and form structural mimics of mammary acini found in
vivo (Petersen et al., 1992). Following extensive passaging of
S1 cells in the absence of EGF, a cell population was derived
(T4-2) that could form tumors in mice (Briand et al., 1996).
These cells form nonpolarized, disorganized masses in 3D cul-
tures that do not growth-arrest (see Bissell et al., 2003 for
review). T4-2 cells do not express p53 (Briand et al., 1996) and
have acquired a number of additional genetic lesions, deter-
mined by array CGH (J.W. Gray and M.J.B., unpublished data).
S1 cells are arguably predisposed cells that can still be held in
check by their microenvironment, whereas T4-2 cells have lost
these controls.Therefore, the system presents an opportunity to
dissect the elements of the microenvironmental regulation that
T4-2 cells have lost.
Extensive analysis of T4-2 and S1 cells has shown that T4-
2 cells have a number of altered signaling pathways. For
instance, EGFR, MAPK, PI3 kinase, and β1-integrin are highly
active, but PTEN and intact dystroglycan are downmodulated.
These changes in signaling mediators reveal how T4-2 cells
have lost the ability to properly transduce the microenvironmen-
tal signals that would otherwise allow differentiation, and sup-
press proliferation and apoptosis (Liu et al., 2004; Wang et al.,
1998; Weaver et al., 1997).Treating T4-2 cells in laminin-rich 3D
gels with blocking antibodies or with pharmacologic reagents
that reduce signaling through these key pathways, causes for-
mation of phenotypically normal acinus-like structures.
Remarkably, the cells also become significantly less tumori-
genic (Liu et al., 2004; Wang et al., 1998, 2002; Weaver et al.,
1997), and this phenomenon of phenotypic reversion can be
extended to other breast cancer cell lines, including metastatic
ones (Wang et al., 2002). A similar “reversion” phenomenon has
been described and exploited for therapy in acute myelogenous
leukemia (AML) patients. Niitsu and colleagues demonstrated
that bone marrow-residual disease, which results in AML
relapses following chemotherapy, is caused by VLA-4-mediated
adhesion of AML cells to bone marrow stromal cells
(Matsunaga et al., 2003). VLA-4-positive AML cells were resis-
tant to apoptosis and persisted in an essentially reverted, dor-
mant state. In T4-2 cells, reestablishment of tissue polarity also
renders the acini-like structures resistant to chemoptherapeutic
agents (Weaver et al., 2002). (Other studies have shown that
coculture of neoplastic and normal cells renders the former phe-
notypically normal [see, e.g., Javaherian et
al., 1998].) These studies demonstrate how
modulating and correcting a genetically dam-
aged cell’s ability to communicate with the
microenvironment could result in the acquisi-
tion of a polarized and phenotypically normal
state, which in turn would make them essentially resistant to
chemotherapy.
It is useful to consider whether the same mechanisms
unraveled in 3D cultures for the maintenance of polarity and tis-
sue structure are also operative in vivo. Given the importance of
laminin-1 in these processes in culture (Weaver et al., 2002),
we asked what cell types in breast produce laminin-1. In vivo, it
is myoepithelial cells that produce laminin-1, and in culture,
myoepithelial cells can replace a laminin-rich gel in conferring
acinus polarity to luminal epithelial cells. The surprising finding
was that a majority of myoepithelial cells isolated from breast
cancers appeared to have lost the ability to produce laminin-1
and could no longer confer polarity to luminal cells (Gudjonsson
et al., 2002). Although production of laminin-1 may not be the
only mechanism by which myoepithelial cells impose tissue
polarity (Runswick et al., 2001), the hypothesis that myoepithe-
lial cells behave as “structural tumor suppressors” for luminal
epithelial cells in the breast (Gomm et al., 1997; Gudjonsson et
al., 2002; Sternlicht et al., 1996) appears to be correct. Since
regulation of adhesion, polarity, and proliferation is of utmost
importance in tissue homeostasis, agents that disrupt the inte-
gration of these pathways could lead to signaling imbalance and
eventually cancer (Sternlicht et al., 1999; Wiseman and Werb,
2002). Moreover, if it is true that cancers represent arrested or
improper TSSC development, then pathways such as Notch
and Wnt, which operate both in stem cell maturation and in can-
cer development, must also be tightly regulated by microenvi-
ronmental cues (Beachy et al., 2004).
Stem cells and their microenvironment
In addition to genetic damage to the TSSC, the stroma is also
susceptible to damage from ionizing radiation, and here, epige-
netic changes appear to be even more important (Barcellos-
Hoff and Brooks, 2001). If there were lasting changes to the
composition of the mammary microenvironment, the aberrant
signals would be additional contributing factors to tumor onset
in the irradiated women in the examples cited above. While the
application of γ irradiation to organisms is generally thought to
kill the cells with proliferative potential by inflicting irreparable
genetic lesions, there is also global damage to organs due to
production and/or activation of proteases and growth factors
that can cause systemic alterations to cellular microenviron-
ments (Ferrara, 1993; Wiseman and Werb, 2002). For instance,
in skeletal muscle, the terminally postmitotic multinucleate
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Figure 2. Integration of signaling pathways by the
microenvironment
The important element to consider here is that the
normal microenvironment must integrate what is cor-
rect (tissue-specific functions, differentiation) by giv-
ing the pathways involved the green light, but also
prevent what is wrong (pathways for inappropriate
growth, apoptosis, and cancer). When the microenvi-
ronment becomes aberrant, the opposite will hap-
pen: the normal differentiated state is blocked and
those pathways that were blocked previously now
become operative.
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myofibers are cells that incur little or no detectable damage, as
judged by their apparent normal function and morphology, fol-
lowing high doses of γ irradiation (Goyer and Yin, 1967; Warren,
1943), while the resident muscle stem cells are susceptible
(LaBarge and Blau, 2004; Schultz and McCormick, 1994). It is
clear that γ irradiation causes potentially deleterious effects also
to the skeletal muscle microenvironment. Under normal circum-
stances, muscle stem cells can be isolated and passaged in tis-
sue culture, then injected back into skeletal muscle where they
fuse with the existing muscle fibers during myogenesis.
Interestingly, when the skeletal muscle was γ irradiated prior to
injection of normal muscle stem cells, the TSSCs were shown to
give rise to tumors (Morgan et al., 2002; Murtuza et al., 2002). In
an analogous fashion, mammary epithelial cells harboring a
Trp53 mutation in both alleles were nontumorigenic when
implanted into normal cleared fat pads. When the recipient
mouse stroma was γ irradiated prior to the implantation of unir-
radiated epithelial cells, tumors were formed at a high percent-
age in the injection sites (Barcellos-Hoff and Ravani, 2000).
That the tumors could be the result of stem cell subpopulations
in these studies was implied, but remains to be proven.
Nevertheless, it was made clear by these reports that an other-
wise normal microenvironment was modified globally by the
application of γ irradiation, which in the long run was sufficient to
initiate tumor growth.
What changes might have occurred in the microenviron-
ments of the skeletal muscle and mammary epithelial cells fol-
lowing irradiation? Application of γ irradiation to mammary
tissue was shown to cause the release of TGF-β, among other
molecules, which is a postulated and proven participant in many
of the tumorigenesis models discussed above (Barcellos-Hoff,
1993; Ferrara, 1993; Kenny and Bissell, 2003). Similarly, it is
possible that γ irradiation causes deleterious changes in gene
expression in the resident fibroblasts (Boerma et al., 2003),
which in turn could promote tumorigenesis (Bhowmick et al.,
2004b). Similar changes may occur with age, as quiescent
fibroblasts were shown to produce secreted proteins that were
proproliferative to predisposed breast epithelial cells (Krtolica et
al., 2001). Finally, processes such as wound repair and tissue
regeneration, in which a mitogenic microenvironment is favor-
able to the tissue, may in fact facilitate TSSC-derived tumors.
Muscle and prostate regeneration and wound healing are asso-
ciated with induction of molecules such as hedgehog that are
known to be involved also in tumorigenesis. Gorin’s syndrome,
which results in a high frequency of sporadic tumors, occurs
due to the loss of negative regulation of the hedgehog signaling
apparatus (Beachy et al., 2004). Moreover, hedgehog overex-
pression is known to be sufficient to cause basal cell carcino-
mas that are thought to originate from bulge cells of the skin,
where the skin stem cells reside (Oro et al., 1997; Tumbar et al.,
2004), and there are also examples in intestinal development
and cancer (Sancho et al., 2004).Taken together, these scenar-
ios suggest mechanisms by which a normal environmental
response to irradiation, aging, or other damages could push a
predisposed TSSC toward frank cancer (Figure 1).
Summary view
There is now much evidence that the microenvironment regu-
lates tissue specificity and contributes significantly to tumorige-
nesis. With respect to “cancer stem cells” as potential
originators of cancers, here we propose mechanisms for at
least two important elements in the tumorigenic process that
were predicated on observations in the human population. First,
a genetically damaged TSSC can be held in check for long peri-
ods of time, which can explain the long delay between environ-
mental exposure and/or germ line suppressor mutations and
cancer onset. Second, ionizing radiation, or physical and chem-
ical insults generally, can result in changes to the microenviron-
mental composition that can by themselves trigger mutations in
the stem cells and eventually cancer. We hypothesize that a link
between the two mechanisms exists as a dynamic and recipro-
cal relationship between genetically damaged cells in a tissue
and their microenvironment, whereby damaged cells modify
their environment, which, in turn, in a vicious cycle, brings about
more pathological behavior from the cells, analogous to the
mechanism postulated for normal homeostasis (Bissell et al.,
1982) (Figure 2). Ultimately, it is this relationship that precipi-
tates a deleterious change over many years, resulting in cancer.
Not even a cancer cell is an island. No cell can perform with-
out instruction from its microenvironment, and the latter of
course would not exist without its initial genetic instructions.
Thus, the cellular origin of cancer, while critically important, is
insufficient to explain the process of tumorigenesis. If we are to
consider the tissue-specific stem cell view of cancer, then we
need to learn how to prevent tumor onset without also com-
pletely blocking normal tissue regeneration. Understanding
which cues stimulate a stem cell to get activated may lead to
prophylactic approaches for therapy and possible prevention.
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